Chemocentryx (CCXI) Posts Q2 Loss of 30c/Share, Misses Views

Article Stock Quotes (1) Comments (0)

Chemocentryx (NASDAQ: CCXI) reported Q2 EPS of ($0.30), $0.09 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $1.13 million versus the consensus estimate of $4.75 million.

For earnings history and earnings-related data on Chemocentryx (CCXI) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
• iSoftStone Holdings (ISS) Tops Q1 EPS by 1c; Guides Q2, FY13
• Hollsys (HOLI) Tops Q3 EPS by 1c; Lowers FY13 Outlook

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?